Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma

Pellegrini Cinzia; Maglie Roberto; Argnani Lisa; Pileri Stefano; Zinzani Pier Luigi

首页> 外文期刊>Hematological oncology >Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma

【24h】

Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma

机译：多发性霍奇金淋巴瘤同种异体移植后对聚乙二醇脂质体阿霉素的印象深刻

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hematological oncology》 |2016年第1期|共3页
作者
Pellegrini Cinzia; Maglie Roberto; Argnani Lisa; Pileri Stefano; Zinzani Pier Luigi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
pegylated liposomal doxorubicin; Hodgkin's lymphoma; allogeneic transplantation; response; multi-relapsed;

机译：聚乙二醇脂质体阿霉素;霍奇金淋巴瘤;同种异体移植;反应;多复发;

相似文献

外文文献
中文文献
专利

1. Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma [J] . Pellegrini Cinzia, Maglie Roberto, Argnani Lisa, Hematological oncology . 2016,第1期

机译：多发性霍奇金淋巴瘤同种异体移植后对聚乙二醇脂质体阿霉素的印象深刻
2. Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma | Haematologica [J] . Anne-Sophie Michallet, Yann Guillermin, Benedicte Deau, Haematologica . 2015,第7期

机译：吉西他滨，长春瑞滨，聚乙二醇化脂质体阿霉素和brentuximab的顺序组合，作为在复发或难治性霍奇金淋巴瘤中移植的桥梁方案|血液学
3. Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors [J] . SchmittC.J., DietrichS., HoA.D., Annals of hematology . 2012,第3期

机译：聚乙二醇化脂质体阿霉素替代常规阿霉素是治疗具有心脏危险因素的非霍奇金淋巴瘤患者的一种安全有效的替代方法
4. Modeling of tumor growth incorporating the effect of pegylated liposomal doxorubicin [C] . Dániel András Drexler, Tamás Ferenci, Anna Lovrics, IEEE International Conference on Intelligent Engineering Systems . 2019

机译：结合聚乙二醇化阿霉素作用的肿瘤生长模型
5. Systems pharmacology modeling of rituximab and doxorubicin in non-Hodgkin's lymphoma. [D] . Zhao, Xiaochen. 2016

机译：非霍奇金淋巴瘤中利妥昔单抗和阿霉素的系统药理模型。
6. Sequential combination of gemcitabine vinorelbine pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma [O] . Anne-Sophie Michallet, Yann Guillermin, Benedicte Deau, 2015

机译：吉西他滨长春瑞滨聚乙二醇脂质体阿霉素和brentuximab的顺序组合作为过渡方案治疗复发或难治性霍奇金淋巴瘤
7. PCN206 Clinical and Cost-Effectiveness of Non-Pegylated Liposomal Doxorubicin for Non-Hodgkin Lymphoma: A Systematic Review [O] . Burda A., Zaremba A., Lubonski J., 2013

机译：PCN206非聚乙二醇化脂质体阿霉素治疗非霍奇金淋巴瘤的临床和成本效果：系统评价

Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma

著录项

相似文献

相关主题

期刊订阅